Antihypertensive action of trandolapril and verapamil in spontaneously hypertensive rats after unilateral nephrectomy

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 2, 1998, Pages 284-290

  López Hernández, Francisco J ^a   Flores, Olga ^a   López Novoa, José Miguel ^a   Montero, María J ^a   Carrón, Rosalía ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Aorta; Hypertension; Nephrectomy; Spontaneously hypertensive rat; Trandolapril; Verapamil

Indexed keywords

CLOTIAZEPAM; NORADRENALIN; PLACEBO; POTASSIUM CHLORIDE; TRANDOLAPRIL; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE CONTRACTILITY; HYPERTENSION; MEAN ARTERIAL PRESSURE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; BLOOD PRESSURE; FEMALE; HEART; HYPERTENSION; INDOLES; NEPHRECTOMY; NITROPRUSSIDE; NOREPINEPHRINE; POTASSIUM CHLORIDE; RATS; RATS, INBRED SHR; VASOCONSTRICTION; VASODILATOR AGENTS; VERAPAMIL;

EID: 0345310021     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199808000-00016     Document Type: Article

References (39)

1. Packer CS. Changes in arterial smooth muscle contractility, contractile proteins, and arterial wall structure in spontaneous hypertension. Proc Soc Exp Biol Med 1994;207(2):148-74.
2. Diez J, Coca A, De Teresa E, Laviades C, Lopez-Sendon JL, Tamargo J, eds. Remodelado y reparación cardiovascular. Madrid: Ed. Ergon, S.A., 1995.
3. Marin J. Mechanisms involved in the increased vascular resistance in hypertension. J Auton Pharmacol 1993;13:127-76.
4. Korner PI. Causal and homeostatic factors in hypertension. Clin Sci 1982;62:15-26s.
5. Folkow B. Early structural changes in hypertension: pathophysiology and clinical consequences. J Cardiovasc Pharmacol 1993; 22(suppl 1):S1-6.
6. Nava E, Luscher TF. Endothelium-derived vasoactive factors in hypertension: nitric oxide and endothelin. J Hypertens 1995;13(suppl 2):S39-48.
7. Karlstrom G, Folkow B, Gothberg G. The humoral renal antihypertensive system: nervous and haemodynamic effects in normotensive and unclipped renal hypertensive rats. Am J Med Sci 1988;31(4):258-62.
8. Karlstrom G, Arnman V, Bergstrom G, Bohman S-O, Rudenstam J, Gothberg G. Do angiotensin converting enzyme inhibitors lower blood pressure in the rat partly via the humorally mediated antihypertensive system of the renal medulla? J Hypertens 1990;8:501-13.
9. Folkow B, Karlström G. Age- and pressure dependent changes of systemic resistance vessels concerning the relationship between geometric design, wall distensibility, vascular reactivity and smooth muscle sensitivity. Acta Physiol Scand 1984;122:17-33.
10. Mulvany MJ, Aalkjær C. Structure and function of small arteries. Physiol Rev 1990;70(4):921-61.
11. Lee MRKW. Vascular changes at the prehypertensive phase in the mesenteric arteries from the spontaneously hypertensive rats. Blood Vessels 1983;22:105-26.
12. Griffin KA, Bidani AK, Ouyang AJ, Churchill VEM, Churchill PC. Role of endothelium-derived nitric oxide in hemodynamic adaptations after graded renal mass reduction. Am J Physiol 1993;264:R1254-9.
13. Anderson S, Brenner M. The critical role of nephron mass and of intraglomerular pressure for initiation and progression of experimental hypertensive-renal disorders. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis and management. New York: Raven Press, 1990:1163-76.
14. Byrom FB, Wilson CA. A plethysmographic method of measuring blood pressure in the rat. J Physiol 1938;93:301-4.
15. Guyton AC. Renal function curve - a key to understanding the pathogenesis of hypertension. Hypertension 1987;2:274-80.
16. Epstein M. Calcium antagonists and the kidney. J Cardiovasc Pharmacol 1994;24(suppl A):S18-24.
17. Stefansig A, Amann K, Ritz E. To prevent progression: ACE inhibitors, calcium antagonist or both? Nephrol Dial Transplant 1995;10(2):151-3.
18. Anderson S. Mecanismos de la nefrosclerosis y de la glomerulosclerosis. In: Izzo JL, Black HR, eds. Primer de hipertensión. Barcelona: Medical Trends, S.L. (Council on High Blood Pressure Research, American Heart Association), 1996:169-72.
19. Roman RJ. Autorregulación del flujo sanguíneo renal y cerebral. In: Izzo JL, Black HR, eds. Primer de hipertensión. Barcelona: Medical Trends, S.L. (Council on High Blood Pressure Research, American Heart Association), 1996:101-3.
20. Wang X, Aukland K, Iversen BM. Autoregulation of total and zonal glomerular filtration rate in spontaneously hypertensive rats during antihypertensive therapy. J Cardiovasc Pharmacol 1996;28:833-41.
21. Grif KA, Bidani AK, Picken M, Ellis VR, Churchill PC. Prostaglandins do not mediate impaired autorregulation or increased renin secretion in remnant rat kidneys. Am J Physiol 1992;263(6):F1057-62.
22. Bidani AK, Griffin KA, Plott W, Schwartz MM. Renal ablation acutely transforms "benign" hypertension to "malignant" nephrosclerosis in hypertensive rats. Hypertension 1994;24(3): 309-16.
23. Mulvany MJ. Determinants of vascular structure. J Cardiovasc Pharmacol 1992;19(suppl 5):S1-6.
24. Folkow B. Hypertensive structural changes in systemic precapillary resistance vessels: how important are they for in vivo haemodynamics? J Hypertens 1995;13:1546-59.
25. Jespersen LT, Nyborg NCB, Pedersen OL, Mikkelsen EO, Mulvany MJ. Cardiac mass and peripheral vascular structure in hydralazine-treated spontaneously hypertensive rats. Hypertension 1985;7:734-41.
26. Nyborg NCB, Mulvany MJ. Lack of effect of antihypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats. Cardiovasc Res 1985;19:528-36.
27. Owens OK. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 1987;9:178-87.
28. Johnston CI. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 1994; 23(2):258-68.
29. Waeber B, Brunner HR. Cardiovascular hypertrophy: role of angiotensin II and bradykinin. J Cardiovasc Pharmacol 1996; 27(suppl 2):S36-40.
30. Takase H, Moreau P, Kung CF, Nava E, Luscher TF. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Hypertension 1996;27:25-31.
31. Benetos A, Blouazziz H, Safar M. Salt-sensitivity and bradykinin activity in rats. Agents Actions 1992;38(suppl 2):228-34.
32. Katori M, Majima M, Mohsin SSJ, Hazanuka M, Mizogami S, Ofushi S. Essential role of kallikrein-kinin system in suppression of blood pressure rise during the developmental stage of hypertension induced by deoxycorticosterone acetate-salt in rats. Agents Actions 1992;38(suppl 2):235-42.
33. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for the release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990;81:1762-7.
34. Panza JA, Quyyumi AA, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
35. Shimamura K, Osugi S, Moriyama K, Sunano S. Impairment and protection of endothelium dependent relaxation in aortae of various strains of spontaneously hypertensive rats. J Cardiovasc Pharmacol 1991;17(suppl 3):S133-6.
36. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-42.
37. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hidralazine on endothelial function in hypertensive rats. Hypertension 1990;16:532-40.
38. Wiemer G, Scholkens Ba, Becker RHA, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 1991;18:558-63.
39. Novosel D, Lang MG, Noll G, Luscher TF. Endothelial dysfunction in aorta of the spontaneously hypertensive, stroke-prone, rat: effect of therapy with verapamil and trandolapril alone and in combination. J Cardiovasc Pharmacol 1994;24:979-85.